Royal Philips introduced two new balloons to its Stellarex 0.035-inch low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035-inch low-dose DCBs have received...
Drug-Eluting Balloons
This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.
-
-
October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no statistically significant mortality increase.
-
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from...
-
Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its Virtue Sirolimus-...
News | Drug-Eluting Balloons | October 15, 2019
October 15, 2019 — Royal Philips introduced two new balloons to its Stellarex 0.035-inch low-dose...
News | Drug-Eluting Balloons | October 10, 2019
October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no...
Videos | TCT | October 04, 2019
News | Drug-Eluting Balloons | September 20, 2019
September 20, 2019 — Orchestra BioMed Inc., in partnership with Terumo Corp. announced the company has secured...
News | Peripheral Artery Disease (PAD) | August 27, 2019
August 27, 2019 — Concept Medical was recently granted Breakthrough Therapy designation by the U.S. Food and Drug...
News | Peripheral Artery Disease (PAD) | August 14, 2019
August 14, 2019 — Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food...
News | Drug-Eluting Balloons | August 02, 2019
August 2, 2019 — B. Braun Interventional Systems Inc. (BIS) announced the U.S. Food and Drug Administration (FDA)...
News | Drug-Eluting Balloons | June 13, 2019
June 13, 2019 — Orchestra BioMed Inc. announced it has formed a global strategic partnership with Terumo Corp. for...
News | Drug-Eluting Balloons | May 29, 2019
May 29, 2019 — Philips announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE...
News | Drug-Eluting Balloons | May 02, 2019
Concept Medical Inc. Granted Breakthrough Device Designation for MagicTouch Sirolimus Coated Balloon
May 2, 2019 — Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and...
Technology | Drug-Eluting Balloons | April 24, 2019
April 24, 2019 — Orchestra BioMed Inc. has secured Breakthrough Device designation by the U.S. Food and Drug...
News | Drug-Eluting Balloons | March 06, 2019
March 6, 2019 – Swiss-based M.A. MedAlliance SA has been granted Breakthrough Device Designation from the U.S. Food...
News | Drug-Eluting Balloons | January 28, 2019
January 28, 2019 — Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated...
News | Peripheral Artery Disease (PAD) | January 17, 2019
January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter...
News | Drug-Eluting Balloons | September 25, 2018
September 25, 2018 — Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty...
